PortViewPortView
ICON Public Limited logo

ICON Public Limited (ICLR) Stock Analysis

NASDAQHealthcareMedical - Diagnostics & Research

$160.70-0.43%
1-year price historyRange $80.08 – $202.92
52-week range$160.70
$66.57$203.91

What ICON Public Limited does

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Key metrics

Market cap
$12.30B
P/E (TTM)
13.11
EPS (TTM)
$12.26
Beta
1.20
Dividend yield
0.00%
Revenue / share
$107.39
50-day avg
$167.47
200-day avg
$147.38
52-week high
$203.91
52-week low
$66.57
CEO
Barry Balfe

ETFs linked to ICLR

Broad-market and Healthcare sector ETFs an investor holding ICON Public Limited is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ICLR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ICLR in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for ICON Public Limited?
ICON Public Limited trades under the ticker ICLR on NASDAQ.
Which exchange is ICLR listed on?
ICLR is listed on NASDAQ.
What sector does ICON Public Limited operate in?
ICON Public Limited is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
How can PortView help analyze ICLR in a portfolio?
PortView shows ICLR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.